Related Experiment Video
Updated: May 12, 2026
08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Proximal myopathy: diagnostic approach and initial management.
Ernest Suresh1, Sunil Wimalaratna
1Department of Medicine, Alexandra Hospital, Singapore, Singapore. dr_esuresh@hotmail.com
Postgraduate Medical Journal
|April 19, 2013
Summary
Proximal myopathy causes symmetrical limb weakness. Early diagnosis and targeted treatments, from addressing toxic exposures to managing inflammatory myopathies, are crucial for effective patient outcomes.
Area of Science:
- Neurology
- Rheumatology
- Genetics
Background:
- Proximal myopathy is characterized by symmetrical weakness in the limbs.
- Numerous causes exist, including toxic, metabolic, endocrine, inflammatory, hereditary, and neoplastic conditions.
Purpose of the Study:
- To outline a diagnostic and management strategy for proximal myopathy.
- To differentiate proximal myopathy from similar conditions and identify urgent cases.
- To guide the etiological investigation and treatment selection.
Main Methods:
- Clinical assessment focusing on distinguishing features and urgent signs.
- Initial laboratory tests: creatine kinase, thyroid function, vitamin D levels.
- Further investigations: neurophysiological studies, muscle imaging, biopsy, malignancy screening, antibody testing (e.g., anti-Jo1).
Main Results:
- Diagnostic approach categorizes causes into toxic, metabolic, endocrine, inflammatory, hereditary, etc.
- Prompt identification of cardiac, respiratory, or pharyngeal involvement is critical.
- Specific tests aid in diagnosing idiopathic inflammatory myopathies (IIM) and hereditary myopathies.
Conclusions:
- Effective management of proximal myopathy requires accurate etiological diagnosis.
- Treatment strategies vary widely, from agent removal and metabolic correction to immunosuppression for IIM and supportive care for muscular dystrophies.
- Multidisciplinary approach is essential for optimal patient care.
Keywords:
proximal myopathy
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...